Company Filing History:
10 out of 1,860 
3 out of 3,923 
3 out of 2,595 
Years Active: 1999-2024
Title: Innovations by Hideho Okada: Pioneering Cancer Treatment
Introduction
Hideho Okada is a prominent inventor based in Pittsburgh, PA, known for his significant contributions to the field of cancer treatment. With a portfolio of twelve patents, Okada's innovative work lies at the intersection of advanced medical research and practical applications, ultimately aiming to improve patient outcomes in cancer therapy.
Latest Patents
Two of Okada's latest patents showcase his forward-thinking approach in the fight against cancer. The first patent focuses on the "Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor." This invention provides compositions and methods for treating diseases associated with the expression of EGFRvIII. It involves the use of a chimeric antigen receptor (CAR) specific to EGFRvIII, which includes vectors and recombinant T cells designed to enhance therapeutic efficacy.
The second patent, titled "Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response," presents a peptide derived from the interleukin-13 receptor α2, functioning as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. This invention has potential as a vaccine for glioma, with formulations applicable for both medical and veterinary use. Additionally, it includes peptides derived from the Eph family of tyrosine kinase receptors that can also be formulated for glioma vaccine applications.
Career Highlights
Hideho Okada has had a distinguished career, marked by his affiliations with reputable institutions and organizations. Notably, he has worked at the University of Pittsburgh, where he has contributed significantly to research and innovation in cancer therapy. His tenure at Novartis AG— a leading global healthcare company— further underscores his commitment to advancing medical science and patient care through innovative drug development.
Collaborations
Throughout his career, Okada has collaborated with esteemed colleagues, such as Walter J. Storkus and Jennifer Brogdon. These collaborations have facilitated groundbreaking research efforts, resulting in advancements that not only contribute to the scientific community but also pave the way for new therapeutic options for patients.
Conclusion
In conclusion, Hideho Okada’s journey as an inventor reflects his dedication to innovation in cancer treatment. His impactful patents and collaborations highlight his role in shaping the future of medical research. Through his inventiveness, Okada continues to contribute valuable insights and solutions aimed at combating cancer, demonstrating the vital importance of innovation in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.